Iovance Biotherapeutics, Inc.

This study tested a new treatment for people with advanced melanoma that has spread or cannot be removed. The treatment uses a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), which are grown in a lab and then given back to the patient. The goal was to se…

This early-phase study tested a new cell therapy called IOV-2001 in 7 patients with chronic lymphocytic leukemia or small lymphocytic lymphoma that had stopped responding to standard treatments. The therapy uses a patient's own immune cells to fight the cancer. The main goals wer…